Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer.
Oncotarget（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined